New data challenge common beliefs about antihistamines, corticosteroids, and vaccines in chronic urticaria, with practical ...

More than two years after its approval, only about 60 patients across the U.S., Middle East, and Europe have been treated with the gene-editing therapy. Specialists at four sickle centers told STAT ...

We discuss financial outlooks from Novo Nordisk and Eli Lilly, a closer look at why manufacturing problems have slowed the ...

Researchers have developed a model to explain the science of near-death experiences. Others have challenged it.

The humble radio antenna has become more of a design feature in recent years, but sometimes the shape is dictated by function ...

Novo Nordisk says that more than 170,000 Americans are taking its new GLP-1 pill. Related news is on GLP-1 drugs' impact on heart failure events in diabetes patients; the intersection between obesity ...